3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
4
Neoplasms
3
Breast Neoplasms
3
Ovarian Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Neurofibromatoses
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Melanoma
1
Liver Neoplasms
1
Kidney Neoplasms
1
Hydrocephalus
1
Headache
1
Gallbladder Neoplasms
1
Female Breast Carcinoma
1
Epilepsy
1
Disease Progression
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Brain Edema
1
Abdominal Neoplasms
1
Interventions
Pemetrexed
10
Cisplatin
9
Erlotinib Hydrochloride
8
Carboplatin
7
icotinib
5
Gefitinib
5
Docetaxel
5
endostar protein
3
Zoledronic Acid
3
Radiotherapy
3
Paclitaxel
3
Gemcitabine
3
Endostatins
3
Afatinib
3
tislelizumab
2
pembrolizumab
2
osimertinib
2
lorlatinib
2
flurbiprofen axetil
2
dexamethasone 21-phosphate
2
atezolizumab
2
Vinorelbine
2
Surgical Procedures, Operative
2
Saline Solution
2
Nivolumab
2
Drug Therapy
2
Dexamethasone
2
Chemoradiotherapy
2
trametinib
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Carcinoma, Non-Small-Cell Lung
×
Sevoflurane
×
Clear all
NCT06330038
2026-04-20
GASTIVA
Samsung Medical Center
Phase 4
Recruiting
5,384 enrolled